It is a modular urinalysis workflow launched by DIRUI, which can meet the realistic needs of clinical laboratories for automated and high-throughput urine testing.

Stay up-to-date with the latest happenings in the rapidly evolving field of In Vitro Diagnostics (IVD) in China.

Snibe reference testing laboratory passed all nine projects (seven in clinical enzymology, one in vitamins and one in hormones) in which it participated in the IFCC-RELA 2022.

According to CAIVD statistics, at present, the main in vitro diagnostic listed enterprises total: 62. They cover three segments: production, service and distribution. Among them, 46 are production enterprises, 11 are service enterprises and 5 are distribution enterprises.

A collaborative team led by researchers has re-engineered the process of microbial pathogen identification in blood samples from pediatric sepsis patients using the Wyss Institute's FcMBL broad-spectrum pathogen capture technology.

In addition, personnel, equipment, and facilities from the acquired companies will expand Reaction Biology’s presence in Germany while enabling its global customers to leverage Bioassay’s expansive portfolio of regulated clinical and commercial services.

Centrifugal microfluidics belongs to a branch of microfluidics, which refers to the control of microfluidics by centrifugal force to drive liquid flow. It integrates the basic operations involved in biology and chemistry on a small disc-shaped chip, so it is also called Lab-on-a-Disc (LOAD).

General Electric’s board of directors approved its planned spin off of its healthcare business. The new firm, called GE HealthCare, is expected to start trading on Nasdaq on Jan. 4., under the ticker “GEHC.”

KSL Pulse Scientific said Tuesday it will distribute Lucira Health's disposable molecular test for COVID-19 and influenzas A and B for over-the-counter use in Canada.

On Dec. 1st, Sansure announced that its bordetella pertussis nucleic acid test kit (PCR-fluorescent probe method) obtained the certificate approved by NMPA.

HemoSonics said Wednesday it secured US Food and Drug Administration 510(k) clearance for the company's QStat Cartridge assay to provide point-of-care hemostasis data during trauma and liver transplantation procedures.

Ceres Nanosciences said on Thursday that it has received $1.4 million in new funding from the National Institutes of Health RADx initiative to expand a network of wastewater-based epidemiology centers of excellence that was established with $8.2 million in prior RADx funding.